Gastric mucosal infiltration by Helicobacter pylori favours bacterial survival after treatment

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 2, 1996, Pages 181-185

  Neri, M ^b   Susi, D ^a   Bovani, I ^a   Laterza, F ^b   Porreca, E ^b   Cuccurullo, F ^b  

^a S Timoteo Hospital   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE;

ADULT; ARTICLE; ELECTRON MICROSCOPY; ENDOSCOPY; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH MUCOSA;

EID: 0029870039     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.713893000.x     Document Type: Article

References (31)

1. Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991; 324: 1043-8.
2. Blaser MJ. Gastric Campylobacter-like organisms, gastritis and peptic ulcer disease. Gastroenterology 1987; 93: 571-83.
3. Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233-5.
4. Graham DY. Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J Gastroenterol Hepatol 1991; 6: 105-13.
5. Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989; 96: 615-25.
6. Marshall BJ, Goodwill CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437-1442.
7. Correa P. Is gastric carcinoma an infectious disease ? N Engl J Med 1991; 325: 1170-1.
8. National Institutes of Health consensus conference. "Helicobacter pylori in peptic ulcer disease". JAMA 1994; 272: 65-9.
9. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493-6.
10. Cutler AF, Schubert TT. Patient factors affecting Helicobacter eradication with triple therapy. Am J Gastroenterol 1993; 88: 505-9.
11. Glupczynski Y, Burette A. Drug therapy for Helicobacter pylori infection: problems and pitfalls. Am J Gastroenterol 1990; 85: 1545-51.
12. Hazell SL, Lee A, Brady L, Hennessy W. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis 1986; 153: 658-63.
13. Bode G, Melfertheiner P, Ditschuneit H. Pathogenetic implications of ultrastructural findings in Campylobacter pylori related gastroduodenal disease. Scand J Gastroenterol 1988; 23 (Suppl 142): 25-39.
14. Chen XG, Correa P, Offerhaus J. Ultrastructure of the gastric mucosa harbouring Campylobacter-like organisms. Am J Clin Pathol 1988; 86: 575-82.
15. Andersen LP, Hoick S. Possible evidence of invasiveness of Helicobacter (Campylobacter) pylori. Eur J Clin Microbiol Infect Dis 1990; 9: 135-8.
16. Wyle FA, Tarnawski A, Schulman D, Dabros W. Evidence for gastric mucosal cell invasion by C. pylori: an ultrastructural study. J Clin Gastroenterol 1990; 12 (Suppl 1): 592-8.
17. Michetti P, Porta N, Racine L, Kraehenbuhl JP, Blum AL. Polarized madin darby canine Kidney (MDCK) epithelial cell monolayers as a model to study Helicobacter pylori adherence and invasion. Irish J Med Sci 1992; 161 (suppl 10): 46.
18. Evans DG, Evans DJ Jr, Graham DY. Adherence and internalization of Helicobacter pylori by HEp-2 cells. Gastroenterology 1992; 102: 1557-67.
19. Noach LA, Rolf TM, Tytgat GNJ. Electron microscopic study of association between Helicobter pylori and gastric and duodenal mucosa. J Clin Pathol 1994; 47: 699-704.
20. Chan WY, Hui PK, Leung KM, Thomas TMM. Modes of Helicobacter colonization and epithelial damage. Histopatology 1992; 21: 521-8.
21. Neri M, Susi D, Bovani I, Laterza F, Mezzetti A, Cuccurullo F. Bacterial mucosal infiltration in Helicobacter pylori-associated gastritis: histological and clinical consequences. Am J Gastroenterol 1994; 89: 1801-5.
22. Rauws EAJ. Reasons for failure of Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 1993 (Suppl 2): 5: 592-5.
23. Logan RPH, Gummett PA, Schaufelberger HD, et al. Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 1994; 35: 323-6.
24. Axon ATR. The role of acid inhibition in the treatment of Helicobacter pylori infection. Scand J Gastroenterol 1994; 29 (Suppl 201): 16-23.
25. Adamek RJ, Wegener M, Labenz J, Freitag M, Opferkuch W, Ruhl GH. Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy. Am J Gastroenterol 1994; 89: 39-42.
26. Atherton JC, Cullen DJE, Hawkey CJ, Spiller RC. Enhanced eradication of Helicobacter pylori by pre-versus post-prandial amoxicillin suspension with omeprazole: implications for mode of action. Gastroenterology 1994; 106: A41.
27. Fried M, Siegrist H, Frei R, et al. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut 1994; 35: 23-26.
28. Bathia SJ, Kochar N, Abraham P, Nair NG, Mehta AP. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol 1989; 27: 2328-30.
29. Daw MA, Deegan P, Leen E, O'Morain C. Short report: the effect of omeprazole on Helicobacter pyrlori and associated gastritis. Aliment Pharmacol Therap 1991; 5: 435-9.
30. Fraser AG, Bickley J, Owen RJ, Pounder RE. DNA finger prints of Helicobacter pylori before and after treatment with omeprazole. J Clin Pathol 1992; 45: 1062-5.
31. Johnson EW, Suchower LJ, Dancer NA, Joelsson BE, Neil GA. Omeprazole plus amoxicillin (dual) therapy for H. pylori infection: a review and meta analysis of the literature. Am J Gastroenterol 1994; 89: 1384.